| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 18 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-23 |
4 |
B |
$9.90 |
$808,048 |
I/I |
81,621 |
14,680,244 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-12 |
4 |
B |
$9.92 |
$198,400 |
I/I |
20,000 |
14,774,942 |
2.25 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2013-12-20 |
4 |
OE |
$9.93 |
$1,038,595 |
D/D |
76,867 |
3,391,920 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-04 |
4 |
B |
$9.98 |
$12,016 |
I/I |
1,204 |
14,690,449 |
2.17 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-11 |
4 |
B |
$9.99 |
$199,800 |
I/I |
20,000 |
14,754,942 |
2.25 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-13 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
3,531,672 |
2.45 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-24 |
4 |
B |
$10.00 |
$50,010 |
I/I |
5,001 |
14,685,245 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-05 |
4 |
B |
$10.00 |
$86,250 |
I/I |
8,625 |
14,699,074 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-06 |
4 |
B |
$10.00 |
$108,680 |
I/I |
10,868 |
14,709,942 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-01 |
4 |
B |
$10.03 |
$40,120 |
I/I |
4,000 |
14,689,245 |
2.25 |
% |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2004-12-09 |
4 |
OE |
$10.13 |
$358,213 |
D/D |
29,700 |
1,121,364 |
|
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-01-29 |
4 |
B |
$10.18 |
$314,236 |
I/I |
30,868 |
1,107,891 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-21 |
4 |
A |
$10.44 |
$208,800 |
I/I |
20,000 |
1,924,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-24 |
4 |
A |
$10.53 |
$210,600 |
I/I |
20,000 |
1,944,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-09 |
4 |
B |
$10.63 |
$816,278 |
I/I |
76,790 |
12,032,376 |
2.25 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-10 |
4 |
B |
$10.70 |
$495,385 |
I/I |
46,305 |
587,906 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-11 |
4 |
B |
$10.77 |
$627,047 |
I/I |
58,220 |
646,126 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-20 |
4 |
A |
$10.88 |
$217,600 |
I/I |
20,000 |
1,904,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-05-20 |
4 |
B |
$11.04 |
$47,141 |
I/I |
4,270 |
12,071,158 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-19 |
4 |
A |
$11.21 |
$224,200 |
I/I |
20,000 |
1,884,423 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2008-11-19 |
4 |
OE |
$11.25 |
$1,383,561 |
D/D |
83,728 |
2,854,489 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-14 |
4 |
B |
$11.25 |
$56,264 |
I/I |
5,000 |
651,126 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-02-01 |
4 |
A |
$11.40 |
$1,140,000 |
I/I |
100,000 |
1,207,891 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-05-17 |
4 |
B |
$11.45 |
$114,500 |
I/I |
10,000 |
12,066,888 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-09 |
4 |
B |
$11.86 |
$7,116,000 |
I/I |
600,000 |
11,955,586 |
2.25 |
- |
|
634 Records found
|
|
Page 18 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
